HROW - Harrow Health, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
177.72M
Enterprise Value 3
172.05M
Trailing P/E
12.15
Forward P/E 1
26.15
PEG Ratio (5 yr expected) 1
-11.77
Price/Sales (ttm)
3.56
Price/Book (mrq)
7.42
Enterprise Value/Revenue 3
3.44
Enterprise Value/EBITDA 6
-141.03

Trading Information

Stock Price History

Beta (5Y Monthly) 0.23
52-Week Change 324.09%
S&P500 52-Week Change 325.98%
52 Week High 38.99
52 Week Low 34.10
50-Day Moving Average 36.92
200-Day Moving Average 36.21

Share Statistics

Avg Vol (3 month) 3164.7k
Avg Vol (10 day) 395.98k
Shares Outstanding 525.17M
Float 21.05M
% Held by Insiders 16.44%
% Held by Institutions 145.52%
Shares Short (Dec 30, 2019) 41.84M
Short Ratio (Dec 30, 2019) 411.91
Short % of Float (Dec 30, 2019) 47.97%
Short % of Shares Outstanding (Dec 30, 2019) 47.30%
Shares Short (prior month Nov 28, 2019) 41.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Feb 07, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 31.32%
Operating Margin (ttm)-6.41%

Management Effectiveness

Return on Assets (ttm)-4.83%
Return on Equity (ttm)109.39%

Income Statement

Revenue (ttm)49.95M
Revenue Per Share (ttm)2.01
Quarterly Revenue Growth (yoy)18.80%
Gross Profit (ttm)24.85M
EBITDA -1.22M
Net Income Avi to Common (ttm)15.64M
Diluted EPS (ttm)0.58
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.69M
Total Cash Per Share (mrq)1.02
Total Debt (mrq)20.25M
Total Debt/Equity (mrq)85.35
Current Ratio (mrq)2.83
Book Value Per Share (mrq)0.95

Cash Flow Statement

Operating Cash Flow (ttm)-738k
Levered Free Cash Flow (ttm)605k